MSD Animal Health
MSD Animal Health is the animal health subsidiary of Merck & Co., developing and marketing veterinary vaccines, parasiticides, and AI-based herd monitoring technology across nine species for veterinary practices and livestock producers globally.
- Company typePrivate
- Founded1940
- HeadquartersDublin, Ireland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What MSD Animal Health does
MSD Animal Health is the animal health subsidiary of Merck & Co., Inc. (NYSE: MRK), operating globally as a research-driven developer, manufacturer, and marketer of veterinary pharmaceuticals and biological products. Its portfolio spans vaccines, parasiticides, and anti-infectives organized across nine species categories including cattle, sheep, horses, dogs, cats, rabbits, pigs, poultry, and fish, with branded franchises such as Bravecto, Nobivac, Bovilis, NOBIVAC NXT Rabies, and Sense Hub. The company's technology layer includes the Sense Hub AI-based herd monitoring platform, which monitors 190,000 dairy cattle across 900 Brazilian farms and is positioned to grow from 10% to 25% of revenue by 2030, alongside proprietary vaccine platforms using RNA-particle, virus-like particle, and vitamin E-adjuvant technologies.
MSD Animal Health generates revenue primarily through one-time sales of pharmaceuticals and biologics distributed through veterinary practices for companion animals and through direct sales teams for livestock producers. A growing subscription-style revenue stream is emerging from Sense Hub AI monitoring, supported by proprietary data from monitored herds. The company sells through an ecosystem of practice-embedded tools including MSD Animal Health Academy (CVE-accredited CPD), VetHub, VetPerform, VetConsult, Healthier Pets Reminder Service, Chameleon digital design, and the Toxovax E-Shop, which deepen integration with veterinary practice workflows. The Irish operating entity, Intervet Ireland Ltd. t/a MSD Animal Health Ireland Ltd., is headquartered in Leopardstown, Dublin. The company recently acquired Elanco's aqua business (July 2024) to enter aquaculture and divested its Aprilia, Italy manufacturing site to Prange Pharma (April 2026) under a long-term supply agreement, reflecting active portfolio rebalancing toward higher-value biologics and technology platforms.
MSD Animal Health firmographics
Firmographics- Name
- MSD Animal Health
- Legal name
- Intervet Ireland Ltd. t/a MSD Animal Health Ireland Ltd.
- Website
- https://msd-animal-health.ie
- Company type
- Private
- Founded year
- 1940
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MSD Animal Health is the animal health subsidiary of Merck & Co., developing and marketing veterinary vaccines, parasiticides, and AI-based herd monitoring technology across nine species for veterinary practices and livestock producers globally.
- Ownership category
- akta.pro rank
MSD Animal Health industry classification
Industry- Product category
- Veterinary Pharmaceuticals
- NAICS
- Veterinary Services (541940), Veterinary Services (54194)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)
- akta.pro secondary industries
- Multi-site/Corporate Group Operations Platforms (Franchise/MSO Tools, Standardization) (HLAMAGAM), Veterinary Vaccines (Biologics) (HLAMAEAL)
Keywords
Where MSD Animal Health is headquartered
LocationHeadquarters
- HQ city
- Dublin
- HQ country
- Ireland
- HQ region
- Europe
Offices1 record
Markets served
MSD Animal Health business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Marketing or Sales, Supply Chain, Personnel
Revenue model
- Veterinary Pharmaceuticals and Biologics: Core revenue from pharmaceutical and biological products including vaccines, parasiticides, anti-infectives, and other veterinary medicines for companion animals and livestock.
- Animal Health Technology Solutions: Revenue from technology platforms including Sense Hub herd monitoring systems, contributing to the company's expansion beyond traditional pharmaceuticals. Expected to grow from 10% to 25% of revenue by 2030.
- Aquaculture Business: Revenue from aqua business acquired from Elanco in July 2024, expanding MSD Animal Health's presence in fish health products.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
MSD Animal Health product offering
Product offeringCore offering
MSD Animal Health develops, manufactures, and markets a comprehensive portfolio of veterinary pharmaceuticals, biological products (vaccines), parasiticides, and anti-infectives for companion animals and livestock. The company also offers proprietary AI-powered technology platforms such as Sense Hub for dairy cattle herd monitoring and identification, alongside digital services supporting veterinary practice operations.
Product overview
MSD Animal Health operates as a comprehensive animal health company offering a unified portfolio of veterinary pharmaceutical and biological products across multiple species (cattle, sheep, horses, dogs, cats, rabbits, pigs, poultry, fish). The portfolio includes vaccines (NOBIVAC NXT Rabies, Nobivac Respira Bb, foot-and-mouth disease vaccines), parasite control products (Bravecto), and herd monitoring technology (Sense Hub). Supporting infrastructure includes educational platforms (MSD Animal Health Academy), practice management tools (VetHub, VetPerform, VetConsult), digital services (Chameleon, Healthier Pets Reminder Service), and ecommerce (Toxovax E-Shop). The company serves both farm animal (cattle, sheep, pigs, poultry, fish) and companion animal (dogs, cats, horses, rabbits) segments through its species-organized product structure.
Differentiator
Problem solved
Functional benefit
Brands
- NOBIVAC NXT Rabies: Rabies vaccine portfolio using advanced RNA-particle technology launched in June 2024
- Nobivac Respira Bb
- Sense Hub
- Chameleon
- VetHub
- MSD Animal Health Academy
- Healthier Pets Reminder
Products and services
- Sense Hub AI-based herd monitoring and identification technology that monitors dairy cattle vital signs and behavior for early disease detection. Sold to commercial cattle producers, with 190,000 animals monitored across 900 farms in Brazil.
- NOBIVAC NXT Rabies portfolio Advanced rabies vaccine portfolio for cats and dogs using RNA-particle technology, formulated without adjuvants or preservatives to stimulate comprehensive immune responses. Sold through veterinary practices.
- Nobivac Respira Bb Novel injectable Bordetella bronchiseptica vaccine for dogs using a vitamin E-based oil-in-water adjuvant with purified fimbrial antigen. Provides an injectable alternative to existing intranasal or oral Bordetella vaccines. Sold through veterinary practices.
- Foot-and-Mouth Disease Vaccines Vaccines for foot-and-mouth disease in livestock, including thermostable, recombinant, and DIVA-compatible variants. MSD Animal Health is one of the key players in the global FMD vaccines market, serving livestock farmers.
- MSD Animal Health Academy Online e-learning platform containing courses and webinars for veterinary professionals, many CVE accredited. Access restricted to veterinary practitioners and veterinary nurses with a registered account.
- Chameleon Digital Design Service Digital design and printing service providing personalized communications for veterinary practices including vaccination reminders (SMS, email, or postcard), vaccination certificates, and other client engagement materials.
- Healthier Pets Reminder Service Web-based system allowing veterinary practices to set up text and email parasite treatment reminders for pet owner clients.
- Bovilis Cattle and sheep health product line serving cattle and sheep farmers to improve health and fertility, including vaccines and reproductive management products.
- Bravecto
Quantifiable outcome
- 190,000 animals monitored across 900 farms using Sense Hub technology in Brazil
- +3 more outcomes
Companies that use MSD Animal Health
Customer profileNamed customers3 records
Segments11 records
Ideal customer profiles3 records
MSD Animal Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature10 records
MSD Animal Health partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Elanco Animal HealthcoreMSD Animal Health acquired Elanco's aqua business in July 2024, expanding its presence in the aquaculture health market. This acquisition strengthened MSD Animal Health's portfolio in fish health products and expanded its market coverage in the aquaculture segment.
- Diamond Light Source and Collaborating InstitutionscoreMSD Animal Health is collaborating with researchers at Diamond Light Source and other institutions on a novel virus-like particle vaccine against foot-and-mouth disease. The vaccine is currently undergoing regulatory approvals. This partnership enables access to advanced research capabilities for vaccine development.
- Prange PharmaminorPrange Pharma completed acquisition of the MSD Animal Health manufacturing site in Aprilia, Italy, rebranded as Aprilia Animal Health. The transaction includes a long-term supply partnership to ensure product continuity and expand Prange Pharma's capabilities in animal health manufacturing.
- Mars PetcareminorBoth companies identified as key industry players expanding capacity and compliance systems in the South Asia pet care market. While not formal partners, both compete in the same regional markets.
- Nestlé PurinaminorIdentified as key industry peer in South Asia pet care market alongside MSD Animal Health. Both companies expanding capacity in the rapidly growing regional market.
Scale indicators20 records
Recent moves7 records
Expansion highlights6 records
MSD Animal Health competitors and assessment
Company assessmentDirect peers
- Vetoquinol: Animal health pharmaceutical company with companion animal and livestock products. Smaller-scale direct peer with overlapping parasiticide, anti-infective, and specialty therapeutic franchises.
- Phibro Animal Health: Animal health and nutrition company focused on livestock (cattle, poultry, swine). Comparable in production-animal vaccines, medicated feed additives, and nutritional specialties.
- Boehringer Ingelheim Animal Health: Major animal health division of Boehringer Ingelheim with broad vaccines, parasiticides, and therapeutics portfolio. Direct competitor across companion animal vaccines (e.g., rabies) and livestock biologics.
- Virbac: Independent global animal health company with a portfolio spanning companion animal vaccines, parasiticides, dermatology, and livestock products. Comparable in breadth and species coverage to MSD Animal Health.
- Ceva Santé Animale: Global animal health company focused on vaccines, pharmaceuticals, and equipment for livestock and companion animals. Direct competitor, particularly strong in poultry and swine vaccines.
- Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals company with strong positions in companion animal endocrinology, dermatology, and equine. Comparable in companion animal focus and specialty pharma model.
- Zoetis: The largest pure-play animal health company globally, with a comparable portfolio of vaccines, parasiticides, anti-infectives, and diagnostics across companion and livestock species. Most direct head-to-head competitor to MSD Animal Health in vaccines and parasiticides worldwide.
- Elanco Animal Health: Direct competitor in livestock and companion animal health, recently divested its aqua business to MSD Animal Health. Competes head-to-head in vaccines, parasiticides, and nutritional health products.
Broad incumbents
- IDEXX Laboratories: Dominant veterinary diagnostics company whose in-clinic analyzers and tests complement MSD's therapeutic products. Competes for share of veterinary practice wallet and increasingly in animal-health data and monitoring.
- Mars Petcare: Operates veterinary services, diagnostics (Antech), and pet nutrition. While a competitor in the broader pet health ecosystem (especially South Asia), it overlaps more in services and nutrition than in pharma/biologics, making it a broad incumbent peer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
MSD Animal Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
MSD Animal Health leadership team
Management profileNumber of profiles
MSD Animal Health subsidiaries and ownership
Company hierarchySubsidiaries1 record
MSD Animal Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MSD Animal Health M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MSD Animal Health
What does MSD Animal Health do?
MSD Animal Health develops, manufactures, and markets a comprehensive portfolio of veterinary pharmaceuticals, biological products (vaccines), parasiticides, and anti-infectives for companion animals and livestock. The company also offers proprietary AI-powered technology platforms such as Sense Hub for dairy cattle herd monitoring and identification, alongside digital services supporting veterinary practice operations.
Is MSD Animal Health a public or private company?
MSD Animal Health is a private company. It is classified as corporate owned and is currently operating.
When was MSD Animal Health founded?
MSD Animal Health was founded in 1940. It employs 11 to 50 people.
Where is MSD Animal Health based?
MSD Animal Health is headquartered in Dublin, Ireland, in the Europe region.
How does MSD Animal Health make money?
Three revenue lines are on record. Veterinary Pharmaceuticals and Biologics are the primary driver. The others are animal Health Technology Solutions and aquaculture Business.
Who are MSD Animal Health's main competitors?
Direct peers on record are Vetoquinol, Phibro Animal Health, Boehringer Ingelheim Animal Health, Virbac, Ceva Santé Animale, Dechra Pharmaceuticals, Zoetis and Elanco Animal Health. Broad incumbents are IDEXX Laboratories and Mars Petcare.
Does MSD Animal Health have an API?
No public API is recorded for MSD Animal Health.
What industry is MSD Animal Health in?
MSD Animal Health's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAB, Livestock & Production Animal Therapeutics (Rx), with a secondary code of HLAMAGAM, Multi-site/Corporate Group Operations Platforms (Franchise/MSO Tools, Standardization). Its NAICS code is 541940 and its SIC code is 2836.